hsa-mir-592: hsa-mir-592 is a microRNA that has been implicated in various cancer-related processes and pathways. It has been found to correlate with monosomy 3 tumors, suggesting a potential role in tumor development or progression [PMC7958896]. In breast cancer, hsa-mir-592 expression was markedly elevated, with levels approximately twenty-three times higher than in healthy samples, and it was identified as a regulator of the extrinsic prothrombin activation pathway [PMC6208346]. This microRNA is also part of a group that regulates both extrinsic and intrinsic prothrombin pathways [PMC4512830]. Significant expression differences of hsa-mir-592 have been observed when comparing uterine artery samples to controls [PMC5650163]. In the context of metastatic tumors, hsa-mir-592 was among the miRNAs found to be upregulated [PMC7140886], and it was also more highly deregulated in high-grade disease patients compared to those with low-grade disease [PMC6423615]. Additionally, hsa-mir-592 has been implicated in potentially regulating mRNAs related to preeclampsia and may indirectly affect tick-borne encephalitis virus replication as well [PMC8176413; PMC9167876]. It is also recognized for its contribution to prediction accuracy in miRNA-related studies and can effectively distinguish between high-risk and low-risk groups according to Kaplan–Meier analysis [PMC6208346; PMC9695425].